{
    "organizations": [],
    "uuid": "d23e0600edb00565ae5b1310474a715852df36cf",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-taiwan-leader-biotech-gets-tfda-ap/brief-taiwan-leader-biotech-gets-tfda-approval-for-clinical-trial-of-botanical-drug-leac-102-in-taiwan-idUSL4N1PI4FG",
    "ord_in_thread": 0,
    "title": "BRIEF-Taiwan Leader Biotech gets TFDA approval for clinical trial of botanical drug LEAC-102 in Taiwan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - Taiwan Leader Biotech Corp :\n* Says it gets TFDA approval for clinical trial of botanical drug LEAC-102 in Taiwan\n* LEAC-102 is used for adjunctive therapy of colorectal cancer\n* The clinical trial will start up in May\nSource text in Chinese: goo.gl/1t63QG\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-23T19:51:00.000+02:00",
    "crawled": "2018-01-24T15:41:34.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "taiwan",
        "leader",
        "biotech",
        "corp",
        "say",
        "get",
        "tfda",
        "approval",
        "clinical",
        "trial",
        "botanical",
        "drug",
        "taiwan",
        "used",
        "adjunctive",
        "therapy",
        "colorectal",
        "cancer",
        "clinical",
        "trial",
        "start",
        "may",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}